Because anti-CD40 treatment increased CD8+ T cell infiltration and also upregulation of PD-1 and PD-L1, we tested the hypothesis that a combination of αCD40 and αPD-L1 would induce systemic anti-tumour immunity in this model. The gene discussed is PDCD1; the disease is neoplasm.